A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
Where this comes from
- Record sourced from PubMed, PMID 29506129.
- Also identified by DOI 10.1093/infdis/jiy103 and PMC identifier 6279170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.
Medical subject headings
- Influenza Vaccines
- Influenza, Human
- Zoonoses